
Beijing Tiantan Biological Products Investor Relations Material
Latest events

H1 2025
22 Aug, 2025

Q1 2025
15 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beijing Tiantan Biological Products Co Ltd
Access all reports
Beijing Tiantan Biological Products Co., Ltd. is a biopharmaceutical company that develops, manufactures, and distributes a range of blood-based and vaccine products. The company focuses on producing plasma-derived products, including treatments for immune deficiencies and blood coagulation disorders, as well as vaccines for infectious diseases. Utilizing advanced bioprocessing and quality assurance standards, Beijing Tiantan Biological aims to support healthcare needs in China and potentially in international markets. The company is involved in research to expand its product portfolio within the biologics field. Beijing Tiantan Biological Products is headquartered in Beijing, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
600161
Country
🇨🇳 China